As artificial intelligence (AI) continues to make significant advances, the leaders of clinical trials should not underestimate its capabilities for improving patient recruitment, retention
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
